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Abstract Cerebral blood flow (CBF) is regulated over a
range of systemic blood pressures by the cerebral
autoregulation (CA) control mechanism. This range lies
within the lower and upper limits of autoregulation
(LLA, ULA), beyond which blood pressure drives CBF,
and CA function is considered impaired. A standard
method to determine autoregulation limits noninvasively
using NIRS technology is via the COx measure: a
moving correlation index between mean arterial pressure
and regional oxygen saturation. In the intact region, there
should be no correlation between these variables whereas
in the impaired region, the correlation index should
approximate unity. In practice, however, the data may be
noisy and/or the intact region may often exhibit a
slightly positive relationship. This positive relationship
may render traditional autoregulation limit calculations
difficult to perform, resulting in the need for manual
interpretation of the data using arbitrary thresholds.
Further, the underlying mathematics of the technique are
asymmetric in terms of the results produced for impaired
and intact regions and are, in fact, not computable for
the ideal case within the intact region. In this work, we
propose a novel gradient adjustment method (GACOx) to
enhance the differences in COx values observed in the
intact and impaired regions. Results from a porcine
model (N = 8) are used to demonstrate that GACOx is
successful in determining LLA values where traditional
methods fail. It is shown that the derived GACOx
indices exhibit a mean difference between the intact/
impaired regions of 1.54 ± 0.26 (mean ± SD), compared
to 0.14 ± 0.10 for the traditional COx method. The
GACOx effectively polarizes the COx data in order to
better differentiate the intact and impaired zones and, in
doing so, makes the determination of the LLA and ULA
points a simpler and more consistent task. The method
lends itself to the automation of the robust determination
of autoregulation zone limits.
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1 Introduction
Cerebral blood flow (CBF) is regulated over a range of
systemic blood pressures (BPs) by the cerebral autoregu-
lation (CA) control mechanism, which acts through com-
plex myogenic, neurogenic, and metabolic mechanisms [1].
This range spans a zone of intact autoregulation from the
lower limit of autoregulation (LLA) to the upper limit of
autoregulation (ULA). Unregulated flow, and therefore
impaired CA, occurs at the extremes of blood pressure (i.e.
below the LLA and above the ULA), where cerebral
vasocontrol is no longer able to adequately control vascular
resistance in response to further blood pressure changes. In
these impaired regions, the blood pressure drives the flow
and is therefore positively correlated with it; whereas in the
intact region, cerebral control of blood flow is maintained
in the event of blood pressure changes and no long-term
correlation between the signals exists. This behaviour is
depicted in Fig. 1, which contains a schematic of the
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archetypal pressure-flow relationship for cerebral autoreg-
ulation. In this idealised depiction, the intact region dis-
plays a horizontal plateau indicating that no correlation
between the parameters exists.
The correlation between the pressure drop across the
brain-cerebral perfusion pressure (CPP)—and cerebral
blood flow (CBF) may be quantified using a linear
regression. The derived correlation coefficient, Mx [2],
provides a measure of the coupling between pressure
and cerebral flow. A common non-invasive proxy for
Mx is COx: the cerebral oximetry index [3]. COx is the
correlation coefficient derived from the relationship
between NIRS-based regional oxygen saturation mea-
surement (rSO2) and mean arterial (blood) pressure
(MAP).
The method for calculating COx is presented in Fig. 2.
Plot A in the figure shows the analysis window of period T,
which is run across the acquired rSO2 and MAP signals.
The data within this window are plotted against each other
(plot B). The window length is chosen to capture the
characteristic periodicity of the physiological slow waves
present in the blood pressure signal [4]. In practice, a time
window of 300 s is usually chosen [4–6], although other
window lengths have been suggested [7–10]. Linear
regression of the data is then performed and the Pearson
correlation coefficient calculated for each window position:
R ¼ cov X;Yð Þ= rXrYð Þ ð1Þ
where the vectors X and Y are the two signals under
investigation, cov(X, Y) is the covariance between X and
Y, and rX, ry denote standard deviations: replacing X
and Y by MAP and rSO2 defines the COx measure
(similarly, using CPP and CBF results in the Mx measure.
However, note that many research groups use MAP as a
proxy for CPP and/or CBF velocity as a proxy for CBF
when computing Mx). The window is then slid over the
signal in incremental steps and the process repeated. In
practice, this time step is around 5–10 s, which is chosen
to filter out low frequency components (including cardiac
and respiratory modulations). At each step, a COx value
is calculated and added to an aggregated COx plot (plot C
in Fig. 2), these are then used to form the COx plot often
used in practice, where the values are binned in 5 mmHg
increments (plot D of Fig. 2). The expectation is that a
strong positive correlation exists between MAP and rSO2
in regions of autoregulatory impairment, hence the COx
values will tend to a value of unity. Regions of intact
autoregulation, however, should produce no correlation
between rSO2 and changes in blood pressure and hence
we expect the correlation coefficient (COx) to be zero. In
this ideal case, we therefore expect a step change in the
binned COx values when transitioning from intact to
impaired regions at the LLA or ULA. In practice, how-
ever, the binned data are generally noisy and a COx
threshold value somewhere between 0 and ?1 is used to
differentiate the correlating and non-correlating portions
of the plot. Values used in studies reported elsewhere in
the literature for this threshold are 0.3 [11, 12], 0.4
[13, 14] and 0.5 [3, 15].
There are, however, fundamental problems with the
correlation method described above in two distinct areas:
physiological and mathematical. We describe these in turn:
Fig. 1 Ideal curve showing flat
(zero gradient) portion in the
intact region
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1. The pressure-flow curve may not contain a central
‘flat’ region of zero gradient during intact CA as
depicted in the ideal case of Fig. 1. In practice, a
positive gradient is often found in this region, although
less steep than in the impaired region. (This case is
shown schematically in Fig. 3). The idea that there is
no change in the range of intact autoregulation
originates from Lassen [16], who described the exis-
tence of a constant plateau for values between 60 and
150 mmHg. However, Lucas et al. [17] have reported
on the pitfalls in following Lassen’s premise, and
referred to a reanalysis of Lassen’s data performed by
Heistad and Kontos [18] which challenges the constant
plateau concept. Willie et al. [19, 20] have discussed
the existence of a slope in the intact region, providing
enough evidence that brain perfusion in the intact
region is not constant and, more recently, Donnelly
et al. [21] have also mentioned that a pressure-passive
behaviour above the LLA is commonly observed. The
exact mechanism that causes the functional depen-
dence of CBF has not been determined, but there is
enough evidence to challenge the assumption of zero
slope in the intact region. In the case of such
behaviour, the derived COx value in the intact region
would also tend to unity, making it indistinguishable
from regions of impaired autoregulation.
2. The correlation method itself has a fundamental
characteristic that makes it less suitable for clearly
defining the two regions (even if an intact CA region of
zero slope is present in the data). We expect a strong
correlation near unity for the impaired region as MAP
and rSO2 trend strongly with each other. However,
during the intact region we expect the two signals to be
decoupled. Thus, for some time periods, both signals
may be trending in the same direction, showing an
apparent correlation; and in other time periods the two
signals may be trending in the opposite direction,
showing a negative apparent correlation. Further, there
may be many periods where the two have a mix of
trending and anti-trending behaviour in the same time
window. We thus expect the COx value during intact
CA to vary from ?1 to -1 randomly over time, with
only the average value over time tending to zero (the
expected distribution of the computed points prior to
binning is depicted in Fig. 2, plot C). The COx method
is therefore asymmetric in its behaviour according to
zone. This is true for all such correlation-based
methods: Mx, HVx, PRx, LDx, etc. Further, the
Pearson correlation coefficient will, in theory, ‘blow
up’ for the ideal horizontal relationship between rSO2
and BP. This can be seen from Eq. (1), where the
standard deviation of the rSO2 signal would be zero
and the index at that region become undefined (the
Fig. 2 The process of generating a cerebral oximetry index (COx)
plot. Note that COx values are in fact bounded by [-1 1]
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method therefore requires some noise in the data and/
or a non-horizontal flat region in the curve for this not
to occur).
Taking the above into account, we propose a new method
for partitioning the intact and impaired CA zones. The
technique employs a gradient adjustment prior to per-
forming the correlation analysis, which shifts the expec-
tation from a strong value at unity and a mean value near
zero for the calculated correlation coefficients (COx) to
strong values at ?1 and -1, corresponding to impaired and
intact regions respectively. This facilitates partitioning of
the data and hence aids determination of the LLA and ULA
boundaries. The new method better discriminates corre-
lating and non-correlating signal segments in data used to
determine the status of cerebral autoregulation. However,
the technique could find general applicability in the anal-
ysis of any other signals where regions of correlation and
non-correlation require identification.
2 Methods
2.1 Gradient adjustment method
The gradient adjustment (GA) method significantly
enhances the delineation between impaired and intact
autoregulation zones in the COx plot by manipulating the
underlying relationship so that the intact region is forced to
have a distinct negative gradient while leaving the impaired
regions with a distinct positive gradient. In the method,
which is illustrated schematically in Fig. 4, we may com-
pensate for the possibility of a zero or positive gradient in
the intact region B by transforming the rSO2 values before
calculating the correlation. This is carried out by calcu-
lating the regression line of the rSO2–MAP curve, shown in
Fig. 4a, and subtracting the corresponding values from the
rSO2 signal. The regression line is an equation given by
y xð Þ ¼ mxþ b ð2Þ
where y corresponds to rSO2 values, x to MAP values, m is
the slope of the line and b the intersection of the line with
the y axis. The gradient-adjusted rSO2 is then calculated as
GArSO2 xið Þ ¼ rSO2 xið Þ  y xið Þ ð3Þ
where xi is the MAP value for the corresponding i-th ele-
ment in the data array and y(xi) is the corresponding value
of rSO2 on the regression line. As we expect the overall
gradient to be greater than that of region B and less than A
and C, this gradient adjustment results in a strong negative
slope of the data in region B, while maintaining positive
slopes in regions A and C (this is shown schematically in
Fig. 4b). Thus, by using GArSO2 values instead of the
original rSO2 values, we may calculate a gradient-adjusted
COx (GACOx) plot. The GACOx method effectively
polarizes the COx data in order to better differentiate the
intact and impaired zones and, in doing so, makes the
determination of the LLA and ULA points a simpler and
Fig. 3 Curve showing slightly
positive relationship in the
intact region
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more consistent task. This polarization of the data to the
?1 and -1 values is shown schematically in Fig. 5.
Figure 6 shows an example of a traditional COx plot and
a GACOx plot (this comprises one of the data sets used in
the study described in detail in Sect. 3 below). The tradi-
tional COx plot in the figure is typical of data with a
slightly positive gradient in the intact CA region. It exhibits
tight clustering towards a value of unity across the whole
blood pressure range, making the LLA relatively difficult
to resolve using traditional methods of analysis. However,
after the application of gradient adjustment, a clearly vis-
ible separation appears between the points corresponding
to the intact and impaired regions in the GACOx plot; the
data tending to cluster around values of 1 and -1
respectively.
2.1.1 Comparison methods
Three reference methods were employed for the calculation
of the limits of autoregulation for comparison with
GACOx: manual inspection and two automated algorithms.
These are described below:
1. Manual method The COx plots were printed out for
eight data sets and three of the authors (PSA, AA, DM)
were asked independently to determine the LLA from
the plot. In the event of a disagreement, the manual
LLA value for each animal was defined as the median
of the three evaluations.
2. Automated algorithm 1 A value of 0.5 was set as the
limiting value for the transition between the low-
impaired region and the intact region. The binned data
Fig. 4 a Schematic rSO2–MAP
curve shown with a flat or
slightly positive slope in the
intact zone (region B) and
corresponding linear fit.
b rSO2–MAP curve after
applying the gradient
adjustment (i.e. the GArSO2–
MAP curve). The slope in
region B is now negative, while
in regions A and C the slope is
still positive (rSO2 regional
oxygen saturation, MAP mean
arterial pressure)
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was inspected, starting with the lowest blood pressure
bin, moving up a 5 mmHg bin at each increment. The
LLA was determined as the MAP value corresponding
to the first binned COx below 0.5.
3. Automated algorithm 2 The same procedure as Algo-
rithm 1 but requiring at least 3 consecutive binned
values below the 0.5 threshold before the LLA was
determined. This was done to mitigate against false
detections due to erroneous noisy data points below the
threshold.
The GACOx LLAs were then determined using both a
manual and automated algorithm. For the automated
algorithm the threshold was simply set to zero and the first
point below was determined as the LLA.
2.2 Data and analysis
The analysis of the method presented here was performed
retrospectively based on data from an animal study origi-
nally designed to investigate the characterization of cere-
bral autoregulation. The study consisted of a healthy
porcine model (N = 8, 8 female), aged 8.4 ± 0.5 weeks
(mean ± SD), with a weight of 13.3 ± 1.7 kg (mean ±
SD). The protocol was reviewed and approved by the
PCRS Animal Care and Use Committee. The study was
conducted in GLP like fashion accordance with 21 CFR Part
58 at an Association for Assessment and Accreditation of
Laboratory Animal Care (AAALAC) accredited site. The
following standards in terms of appropriate use of animals
for biomedical research and/or training were adhered to:
The U.S. Animal Welfare Act amendment of 1976 (Title 9,
Code of Federal Regulations, Chapter 1, Sub-chapter A,
parts 1, 2 and 3) and the current U.S. National Institute of
Health’s Guide for the Care and Use of Laboratory Animals
published by the National Research Council.
Fentanyl, isoflurane, propofol and vecuronium were
used as anaesthetic agents and heparin as an anticoagulant.
NIRS sensors (INVOS SAFB-SM) were placed on the
animals’ head between the ears. These were attached to the
monitor (INVOS 5100C oximeter, 5100C-PA preamp unit
(Medtronic, Boulder, CO)). NIRS cerebral signals (both
raw signals and the output rSO2 signal) and a blood pres-
sure signal were collected. The animal was ventilated with
a tidal volume of 6–8 mL/kg, FiO2 was adjusted to main-
tain 95 % arterial saturation and PEEP was 3 cmH2O.
Respiratory rate was adjusted to maintain end-tidal CO2
between 38 and 45 mmHg. Heating pads were used to
maintain normal body temperature as necessary.
The signals used in the analysis were acquired during
episodes of induced haemorrhagic shock and vasocon-
striction using an a-agent (norepinephrine). The protocol
Fig. 5 The polarization of the intact and impaired data caused by the
gradient adjustment of the COx data. These plots should be compared
to the traditional plots (C and D of Fig. 2) (COx cerebral oximetry
index, GACOx gradient adjusted COx measure)
Fig. 6 Example of a COx plot and its corresponding GACOx plot.
COx and GACOx for a single trial. The error bars indicate the
interquartile range (25–75 %) for the binned data. The black square
markers indicate the median of the COx/GACOx values inside the
bin. The bins have a width of 5 mmHg and are centred in MAP values
equal to multiples of 5 (i.e. 5, 10, 15, etc.). After applying the gradient
adjustment, there is a noticeable difference between the values in the
intact and impaired regions (note that the original individual
(unbinned) data points used to calculate the binned data are also
shown in the plots) (COx cerebral oximetry index, GACOx gradient
adjusted COx measure)
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allowed mostly for blood pressure variations which resul-
ted in multiple crossings of the LLA. A few high pressure
spikes were seen in the data but not enough to adequately
define a ULA in most of the cases, hence only LLAs were
considered in this study. The MAP was calculated from the
raw blood pressure signal by an in-house peak detection
algorithm which determines systolic and diastolic blood
pressure on a beat-by-beat basis. This is averaged over 10 s
and output synchronously with rSO2, which was acquired
directly from the pre-amp signal from an INVOS 5100C
regional oximeter (Medtronic, Boulder, CO).
A moving 300 s window was employed to analyse the
MAP and rSO2 signals. This was incremented along the
signals in a series of 10 s steps. The calculated COx metric
values were binned in 5 mmHg blood pressure increments,
and the reference LLAs calculated using the three methods
described in 2.1.1. Bins with fewer than three data points
were not considered as representative and were excluded
from the analysis. Box plots were used to show the relative
(aggregated) distributions of the COx and GACOx data
either side of the determined LLAs. The difference in the
median values of the COx and GACOx data was taken as a
measure of the separation of the intact and impaired data.
3 Results
Figure 7 shows COx and GACOx plots for all the animals
in the study. The plots include the LLAs calculated using
the manual reference method. The position of the LLAs
determined from automated COx and GACOx algorithms
described above are also indicated below each respective
plot. The corresponding linear fits of the MAP versus
rSO2 data, used to adjust the indices, can also be seen in
the top row plots. It may be observed from the figure that
all GACOx plots exhibit a clear transition from positive
to negative values. This is in contrast to the traditional
COx plots, where many of the transition regions are dif-
ficult to discern, hence making LLA identification prob-
lematic. A summary of the calculated LLAs using
GACOx and the reference methods is provided in
Table 1. It can be seen that both automated algorithmic
methods, when used on the traditional COx plot, failed to
identify a number of LLAs due to data not transiting
below the threshold of 0.5 (in fact, the ‘Threshold 3’
algorithm failed for all cases). However, the GACOx
algorithm produced LLAs for all data sets which can be
seen from Fig. 7 to be very close in value to those
determined manually (5 out of the 8 LLAs are in com-
plete agreement with a mean difference of 1.25 mmHg
and a maximum difference of 5 mmHg).
Figure 8 shows the boxplots for the COx values and
GACOx values split either side of their respective
manually derived LLAs to highlight the differences
between the data distributions in the impaired and intact
regions. It may be observed that there is a significant
overlap of COx data points either side of the LLA for the
traditional method whereas a clear difference is apparent
for the GA method. Table 2 contains the difference in the
median values either side of the LLAs for the automated
COx and GACOx methods for each of the eight studies. It
can be seen that these range from 0.06 to 0.37 for the
traditional method, whereas the GA method ranges from
1.05 to 1.80 (dimensionless units). The mean ± SD for this
difference is 0.14 ± 0.10 for the traditional COx and
1.54 ± 0.26 for the GACOx.
4 Discussion
The use of traditional correlation measures for the identi-
fication of the intact and impaired regions of autoregulation
has inherent physiological and mathematical limitations.
Physiologically, there is an inability to differentiate
between intact and impaired regions when a slightly posi-
tive slope exists in the intact region of the rSO2–MAP plot.
Mathematically two issues exist: the asymmetric data
clustering in the intact and impaired zones; and the com-
putation of a correlation coefficient for the intact region
with idealised data (with a horizontal curve) is mathe-
matically impossible. The gradient adjusted method
detailed in this paper was applied to data where the tradi-
tional COx method failed to identify an LLA in most of the
data sets studied—even when a reasonably high threshold
value of 0.5 was employed. A manual assessment of the
data did find LLAs for all data sets, but this was critically
dependent on the subjective interpretation of the reviewers
and required a ‘user-defined’ threshold well above those
currently used in the literature.
The gradient adjustment method proposed here miti-
gates against the existence of a positive slope in the intact
region by altering the underlying rSO2–MAP relationship
so that the intact region exhibits a negative slope while the
impaired regions retain a positive slope. In this way, the
revised GACOx plot exhibits a clear grouping of the data
tending to ?1 for impaired and -1 for intact autoregula-
tion. This allows for a more robust and reliable method for
detecting the decision boundary at the LLA. In fact, in
many cases, the method facilitates the evaluation of
otherwise undefinable limits using algorithms based on the
traditional method (cf. Table 1, COx algorithms). Although
thresholds were obtained manually from the traditional
COx curves, these were based on the individual interpre-
tation of the reviewer and required adjustment of perceived
thresholds which were data dependent and markedly above
those used in practice (0.3–0.5).
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It is obvious that the GA method may be applied to other
correlation-based measures of autoregulation: for example,
a blood volume signal, an ICP signal or a measure of flow
velocity could be used in place of rSO2 in order to apply
this correction to HVx, PRx or Mx respectively (e.g.
GAHVx, GAPRx, GAMx). The work described here is part
of a wider study by the authors to investigate alternative
and adjunct techniques for traditional correlation-based
methods for CA. The method, for example, could prove
useful for the calculation of PRx where some studies have
reported difficulties in differentiating between intact and
impaired regimes exhibiting very small difference (typi-
cally a PRx value as small as 0.2 is associated with
dysautoregulation, compared to 0.0 for intact autoregula-
tion) [22–24].
In previous work [25], the authors developed COx
analysis methods based on data clustering. We compared
the results from a Gaussian mixture model (GMM) data
clustering approaches with the GA method (Table 3). The
GMM method also successfully produced LLAs for all
eight data sets and it can be seen that the GMM method
produced results very similar to the automated GACOx
method, with a RMSD (root mean square of the difference)
of 3.4 mmHg between both algorithms. However, the
GMM method is much more complex than the proposed
gradient adjusted algorithm which, after gradient adjust-
ment, requires only a simple threshold of zero to differ-
entiate between intact and impaired zone data.
Although we have considered the case where the intact
region displays a positive slope and is therefore a con-
founder to the traditional correlation-based COx approach,
it should be noted that distinct (paradoxical) negative
slopes have also been observed in intact regions [26] for
cardiac surgery patients. In this instance, the traditional
COx method will tend to produce values at ?1 and -1 for
the impaired and intact regions respectively and hence the
gradient adjustment method described here would not be
Fig. 8 Box plot of COx/GACOx values below and above the
manually derived LLAs for all data in the study. The line inside the
box represent the median, while the boxes edges represent the 25 and
75 percentiles. The whiskers represent values 1.5 times the box
length. Data points outside this limit are plotted as outliers (COx
cerebral oximetry index, GACOx gradient adjusted COx measure,
LLA lower limit of autoregulation)
Table 2 Difference of the
median values above and below
the manually derived LLAs for
each case for the COx and
GACOx data sets











COx cerebral oximetry index,
GACOx gradient adjusted COx
measure
Table 3 Comparison of gradient adjustment and data clustering
approaches for LLA determination
Method p01 p02 p03 p04 p05 p06 p07 p08
GACOx algorithm 50 40 65 45 45 45 50 60
GMM algorithm 42 43 67 47 42 45 52 60
GACOx gradient adjusted COx measure, GMM Gaussian mixture
model
Table 1 LLAs computed using
various approaches
Method p01 p02 p03 p04 p05 p06 p07 p08
COx (manual) 48 48 65 65 63 52 65 65
COx algorithm (threshold 1) 60 50 FAIL FAIL FAIL FAIL 65 100
COx algorithm (threshold 3) FAIL FAIL FAIL FAIL FAIL FAIL FAIL FAIL
GACOx (manual) 50 42 65 50 45 45 50 58
GACOx algorithm 50 40 65 45 45 45 50 60
COx cerebral oximetry index, GACOx gradient adjusted COx measure
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necessary (although it could still prove useful in accentu-
ating the difference in noisy data).
Note that application of the GACOx method to a real
time algorithm would require a sufficient number of points
to establish a linear fit with statistical meaning. It is nec-
essary to have a minimum number of points spanning
through a range of blood pressures in order for the method
to be able to discern the main autoregulation function
regions.
The study suffers from a number of limitations. These
are described as follows:
The method requires data in both the impaired and intact
regions to successfully alter the gradient so that the intact
region after gradient adjustment is of a negative slope. This
was not a problem for the current study, where the whole
data set was analysed retrospectively. However, in practice,
in order to develop a real-time implementation, this needs
to be considered. As the COx curve is built up, the data
may initially only be confined to one region (intact or
impaired). In this case, gradient adjustment could, for
example, be based on a historical knowledge of the
expected gradients of impaired and intact regions.
Another disadvantage of the reported study is the lack of
ULA data with which to test the method. This was due to
the nature of the study. It is expected that the method will
work for the identification of this upper limit given that the
slope of the MAP versus rSO2 curve is larger in the high
pressure impaired region than in the intact region. How-
ever, this will require data sets containing distinct ULAs to
test the hypothesis that the method is agnostic to whether a
ULA or LLA is considered.
Another disadvantage of the study was that the results
could not be compared directly to an independent reference
signal, as the historical data used had no useful reference
signal for cerebral blood flow (as the original study was not
set up to investigate autoregulation), hence no Mx could be
calculated (nor the corresponding GAMx). However, the
LLAs could be compared with the standard COx measure
derived using various approaches, including recently
developed data clustering methods. Although less than
ideal, it is worth noting that many of the reference signals
that are used in other studies suffer from their own issues.
For example Transcranial Doppler, which is required to
calculate the Mx measure, requires manual intervention,
does not work for some patients and/or works intermit-
tently, and can be very noisy [3].
5 Conclusion
It is now recognised that real data behaves in a much more
complex way than the traditional Lassen curve indicates,
with both positive and negative correlations having been
observed in practice between rSO2 and MAP during intact
autoregulation regimes. The proposed gradient adjustment
technique is simple to implement and significantly aids in
the automatic extraction of the limits of autoregulation. We
successfully applied the method to a pig study, with
noticeable improvement in terms of successfully deter-
mining lower limit boundaries of autoregulation with val-
ues very close to those determined by manual inspection.
The GACOx method appears promising as a technique for
the robust automation of the identification of the limits of
autoregulation.
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